These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 6199817)

  • 1. [Development and current perspectives of treatment in multiple myeloma].
    Sanz Marca A; López Alvarez J; Aboin Massieu FJ
    Rev Clin Esp; 1983 Nov; 171(3):225-9. PubMed ID: 6199817
    [No Abstract]   [Full Text] [Related]  

  • 2. Supportive therapies in the management of myeloma.
    Ludwig H;
    Oncology (Williston Park); 2004 Mar; 18(3):295-6, 298. PubMed ID: 15065700
    [No Abstract]   [Full Text] [Related]  

  • 3. [Interferon: a new weapon in the therapeutic strategy of multiple myeloma].
    Avvisati G; Petrucci MT; Mandelli F
    Haematologica; 1990; 75 Suppl 4():68-71. PubMed ID: 1705913
    [No Abstract]   [Full Text] [Related]  

  • 4. [Current therapy concepts in patients with multiple myeloma].
    Heyll A; Schneider P; Bauser U; Kobbe G; Hünerlitürkoglu A; Aul C; Haas R
    Dtsch Med Wochenschr; 2000 Oct; 125(40):1201-9. PubMed ID: 11075253
    [No Abstract]   [Full Text] [Related]  

  • 5. Myeloma (multiple).
    Kumar A; Djulbegovic B
    Clin Evid; 2006 Jun; (15):1-29. PubMed ID: 16973003
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of multiple myeloma and arterial thrombosis.
    Raven W; Berghout A; van Houten A; Leebeek FW
    Ann Hematol; 2010 Apr; 89(4):419-20. PubMed ID: 19688212
    [No Abstract]   [Full Text] [Related]  

  • 7. Management of multiple myeloma.
    Richards JD; Singer CR; Tobias JS
    Br J Hosp Med; 1987 May; 37(5):437, 440-2. PubMed ID: 2437986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic strategies and controversies in the treatment of multiple myeloma.
    Bladé J
    Pathol Biol (Paris); 1999 Feb; 47(2):192-8. PubMed ID: 10192888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Multiple myeloma--advances in disease biology and implications for therapy].
    Chou T
    Gan To Kagaku Ryoho; 2001 Sep; 28(9):1206-12. PubMed ID: 11579631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thalidomide as salvage therapy for VAD-refractory multiple myeloma prior to autologous PBSCT.
    Pitini V; Arrigo C; Aloi G; Micali C; La Gattuta G
    Bone Marrow Transplant; 2003 Jun; 31(11):1065; author reply 1067. PubMed ID: 12774062
    [No Abstract]   [Full Text] [Related]  

  • 11. Development of targeted therapies for B-cell non-Hodgkin lymphoma and multiple myeloma.
    Hernandez-Ilizaliturri FJ; Gowda A; Czuczman MS
    Clin Adv Hematol Oncol; 2004 Sep; 2(9):606-18. PubMed ID: 16163245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current clinical and laboratory strategies to augment the efficacy of immunotherapy in multiple myeloma.
    Gorschlüter M; Ziske C; Glasmacher A; Schmidt-Wolf IG
    Clin Cancer Res; 2001 Aug; 7(8):2195-204. PubMed ID: 11489792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The refractory patient: new treatment options.
    Schuster MW
    Oncology (Williston Park); 2003 Oct; 17(10):1333-5. PubMed ID: 14606360
    [No Abstract]   [Full Text] [Related]  

  • 14. [Results, failures and perspectives in therapy of multiple myeloma].
    Bessmel'tsev SS; Abdulkadyrov KM
    Vopr Onkol; 2002; 48(2):146-52. PubMed ID: 12227061
    [No Abstract]   [Full Text] [Related]  

  • 15. Lenalidomide and its role in the management of multiple myeloma.
    Falco P; Cavallo F; Larocca A; Liberati AM; Musto P; Boccadoro M; Palumbo A
    Expert Rev Anticancer Ther; 2008 Jun; 8(6):865-74. PubMed ID: 18533796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy of multiple myeloma].
    La Verde G; Pulsoni A; Petrucci MT; Mandelli F
    Recenti Prog Med; 1997 Apr; 88(4):186-93. PubMed ID: 9206817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [High-dose melphalan in patients with multiple myeloma].
    Moreau P; Le Bonniec M; Harousseau JL
    Bull Cancer; 1999 Mar; 86(3):283-8. PubMed ID: 10210762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative evaluation of the effectiveness of mono- and polychemotherapy programs in patients with multiple myeloma].
    Abdulkadyrov KM; Bessmel'tsev SS
    Klin Med (Mosk); 1992; 70(9-10):57-60. PubMed ID: 1474818
    [No Abstract]   [Full Text] [Related]  

  • 19. Rapid complete remission in multiple myeloma with bortezomib/thalidomide/dexamethasone combination therapy following development of tumor lysis syndrome.
    Chim CS
    Cancer Chemother Pharmacol; 2008 Jun; 62(1):181-2. PubMed ID: 17846773
    [No Abstract]   [Full Text] [Related]  

  • 20. [Skeletal bone lesion and the effectiveness of Bonephos (clodronate) in the comprehensive therapy of multiple myeloma].
    Bessmel'tsev SS; Abdulkadyrov KM
    Vopr Onkol; 1996; 42(4):12-8. PubMed ID: 8928450
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.